Our advisory covered comprehensive legal support on the part of Montis Capital, including legal examination of the company, support in the process of negotiating transaction documentation and in obtaining corporate approvals of the fund. Other investors participating in the round included Nutreco, Aqua-Spark, PFR Life Science and Seventure.

Proteon Pharmaceuticals is a Polish biotechnology company developing bacteriophage technology aimed at reducing the use of antibiotics in animal and fish farming.

Montis Capital is a venture capital fund operating under the PFR Open Innovation programme. Lukasz Dziekonski Tomasz Poninski and Wojtek Szwankowski thank you for your trust and another joint project!

We thank the parties for good cooperation.

Team involved: Krzysztof Laskowski, Paulina Rudowicz-Jastrzębska, Maciej Marczewski.